Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-κB ligand expression in osteoblasts

Masamichi Takami, Ayako Mochizuki, Atsushi Yamada, Keita Tachi, Baohong Zhao, Yoichi Miyamoto, Takahisa Anada, Yoshitomo Honda, Tomio Inoue, Masanori Nakamura, Osamu Suzuki, Ryutaro Kamijo

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Synthetic octacalcium phosphate (OCP) has a potential to enhance new bone formation and exhibits biodegradable characteristics when implanted in experimentally created bone defects. The precise mechanisms of OCP biodegradation remain unclear, though histological observations have revealed that bone-resorbing osteoclasts appear and resorb implanted OCP. To investigate how osteoclasts develop around implanted OCP, we examined osteoclast differentiation using OCP crystals in vitro. Coculturing of mouse bone marrow cells and osteoblasts in OCP-coated cell culture plates induced osteoclast differentiation, whereas that did not occur without coating. Further, addition of bone morphogenetic protein-2 significantly increased the number of osteoclasts in the OCP-coated wells. In the presence of OCP, osteoblasts expressed receptor activator of NF-κB ligand (RANKL), an osteoclast differentiation factor. In addition, when half of each culture well was coated with OCP, osteoclasts were formed in both coated and noncoated areas, suggesting that soluble factors mediate osteoclast differentiation induced by OCP. Also, calcium levels in culture medium were significantly decreased in the presence of OCP, while experimental reduction of calcium from 8.0 to 5.0 mg/dL significantly induced RANKL mRNA expression. These results suggest that OCP itself decreases calcium levels around implanted OCP, which induces osteoclast differentiation through RANKL expression by osteoblasts.

Original languageEnglish
Pages (from-to)3991-4000
Number of pages10
JournalTissue Engineering - Part A
Volume15
Issue number12
DOIs
Publication statusPublished - Dec 1 2009
Externally publishedYes

Fingerprint

Osteoblasts
Osteoclasts
Phosphates
Ligands
Bone
RANK Ligand
Calcium
octacalcium phosphate
Bone and Bones
Bone Morphogenetic Protein 2
Biodegradation
Cell culture
Osteogenesis
Bone Marrow Cells
Culture Media
Cell Culture Techniques
Cells

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering

Cite this

Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-κB ligand expression in osteoblasts. / Takami, Masamichi; Mochizuki, Ayako; Yamada, Atsushi; Tachi, Keita; Zhao, Baohong; Miyamoto, Yoichi; Anada, Takahisa; Honda, Yoshitomo; Inoue, Tomio; Nakamura, Masanori; Suzuki, Osamu; Kamijo, Ryutaro.

In: Tissue Engineering - Part A, Vol. 15, No. 12, 01.12.2009, p. 3991-4000.

Research output: Contribution to journalArticle

Takami, M, Mochizuki, A, Yamada, A, Tachi, K, Zhao, B, Miyamoto, Y, Anada, T, Honda, Y, Inoue, T, Nakamura, M, Suzuki, O & Kamijo, R 2009, 'Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-κB ligand expression in osteoblasts', Tissue Engineering - Part A, vol. 15, no. 12, pp. 3991-4000. https://doi.org/10.1089/ten.tea.2009.0065
Takami, Masamichi ; Mochizuki, Ayako ; Yamada, Atsushi ; Tachi, Keita ; Zhao, Baohong ; Miyamoto, Yoichi ; Anada, Takahisa ; Honda, Yoshitomo ; Inoue, Tomio ; Nakamura, Masanori ; Suzuki, Osamu ; Kamijo, Ryutaro. / Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-κB ligand expression in osteoblasts. In: Tissue Engineering - Part A. 2009 ; Vol. 15, No. 12. pp. 3991-4000.
@article{1d1ce046b97a4fc69e14058d42375d8c,
title = "Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-κB ligand expression in osteoblasts",
abstract = "Synthetic octacalcium phosphate (OCP) has a potential to enhance new bone formation and exhibits biodegradable characteristics when implanted in experimentally created bone defects. The precise mechanisms of OCP biodegradation remain unclear, though histological observations have revealed that bone-resorbing osteoclasts appear and resorb implanted OCP. To investigate how osteoclasts develop around implanted OCP, we examined osteoclast differentiation using OCP crystals in vitro. Coculturing of mouse bone marrow cells and osteoblasts in OCP-coated cell culture plates induced osteoclast differentiation, whereas that did not occur without coating. Further, addition of bone morphogenetic protein-2 significantly increased the number of osteoclasts in the OCP-coated wells. In the presence of OCP, osteoblasts expressed receptor activator of NF-κB ligand (RANKL), an osteoclast differentiation factor. In addition, when half of each culture well was coated with OCP, osteoclasts were formed in both coated and noncoated areas, suggesting that soluble factors mediate osteoclast differentiation induced by OCP. Also, calcium levels in culture medium were significantly decreased in the presence of OCP, while experimental reduction of calcium from 8.0 to 5.0 mg/dL significantly induced RANKL mRNA expression. These results suggest that OCP itself decreases calcium levels around implanted OCP, which induces osteoclast differentiation through RANKL expression by osteoblasts.",
author = "Masamichi Takami and Ayako Mochizuki and Atsushi Yamada and Keita Tachi and Baohong Zhao and Yoichi Miyamoto and Takahisa Anada and Yoshitomo Honda and Tomio Inoue and Masanori Nakamura and Osamu Suzuki and Ryutaro Kamijo",
year = "2009",
month = "12",
day = "1",
doi = "10.1089/ten.tea.2009.0065",
language = "English",
volume = "15",
pages = "3991--4000",
journal = "Tissue Engineering - Part A.",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-κB ligand expression in osteoblasts

AU - Takami, Masamichi

AU - Mochizuki, Ayako

AU - Yamada, Atsushi

AU - Tachi, Keita

AU - Zhao, Baohong

AU - Miyamoto, Yoichi

AU - Anada, Takahisa

AU - Honda, Yoshitomo

AU - Inoue, Tomio

AU - Nakamura, Masanori

AU - Suzuki, Osamu

AU - Kamijo, Ryutaro

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Synthetic octacalcium phosphate (OCP) has a potential to enhance new bone formation and exhibits biodegradable characteristics when implanted in experimentally created bone defects. The precise mechanisms of OCP biodegradation remain unclear, though histological observations have revealed that bone-resorbing osteoclasts appear and resorb implanted OCP. To investigate how osteoclasts develop around implanted OCP, we examined osteoclast differentiation using OCP crystals in vitro. Coculturing of mouse bone marrow cells and osteoblasts in OCP-coated cell culture plates induced osteoclast differentiation, whereas that did not occur without coating. Further, addition of bone morphogenetic protein-2 significantly increased the number of osteoclasts in the OCP-coated wells. In the presence of OCP, osteoblasts expressed receptor activator of NF-κB ligand (RANKL), an osteoclast differentiation factor. In addition, when half of each culture well was coated with OCP, osteoclasts were formed in both coated and noncoated areas, suggesting that soluble factors mediate osteoclast differentiation induced by OCP. Also, calcium levels in culture medium were significantly decreased in the presence of OCP, while experimental reduction of calcium from 8.0 to 5.0 mg/dL significantly induced RANKL mRNA expression. These results suggest that OCP itself decreases calcium levels around implanted OCP, which induces osteoclast differentiation through RANKL expression by osteoblasts.

AB - Synthetic octacalcium phosphate (OCP) has a potential to enhance new bone formation and exhibits biodegradable characteristics when implanted in experimentally created bone defects. The precise mechanisms of OCP biodegradation remain unclear, though histological observations have revealed that bone-resorbing osteoclasts appear and resorb implanted OCP. To investigate how osteoclasts develop around implanted OCP, we examined osteoclast differentiation using OCP crystals in vitro. Coculturing of mouse bone marrow cells and osteoblasts in OCP-coated cell culture plates induced osteoclast differentiation, whereas that did not occur without coating. Further, addition of bone morphogenetic protein-2 significantly increased the number of osteoclasts in the OCP-coated wells. In the presence of OCP, osteoblasts expressed receptor activator of NF-κB ligand (RANKL), an osteoclast differentiation factor. In addition, when half of each culture well was coated with OCP, osteoclasts were formed in both coated and noncoated areas, suggesting that soluble factors mediate osteoclast differentiation induced by OCP. Also, calcium levels in culture medium were significantly decreased in the presence of OCP, while experimental reduction of calcium from 8.0 to 5.0 mg/dL significantly induced RANKL mRNA expression. These results suggest that OCP itself decreases calcium levels around implanted OCP, which induces osteoclast differentiation through RANKL expression by osteoblasts.

UR - http://www.scopus.com/inward/record.url?scp=72049127277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72049127277&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2009.0065

DO - 10.1089/ten.tea.2009.0065

M3 - Article

C2 - 19594360

AN - SCOPUS:72049127277

VL - 15

SP - 3991

EP - 4000

JO - Tissue Engineering - Part A.

JF - Tissue Engineering - Part A.

SN - 1937-3341

IS - 12

ER -